Prosecution Insights
Last updated: April 19, 2026

Alar Pharmaceutical Inc.

1 pending office actions

Portfolio Summary

1
Total Pending OAs
1
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17754738 LONG-ACTING INJECTABLE FORMULATIONS OF KETAMINE PAMOATE SALTS ABBAS, ABDULRAHMAN MUSTAFA 1612 Final Rejection Apr 11, 2022

Managing Alar Pharmaceutical Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month